Mouse models of acute and chronic hepatitis E virus infection.

Tianxu Liu1 Xinyue Yang2 Baixun Li2 Qing Fan2 Zihao Yu3 Dong Ying3 Yuebao Li2 Wei Zhang4 Jiajing Wu5 Peiyu Jiang6 Liwei Zheng7 Hongzhen Mao2 Guochao Wei2 Yanning Liu8 Xin Yin9 Fengmin Lu2 Zizheng Zheng3 Weigang Zhang4 Cheng-Feng Qin6 André Gömer10,11 Nicola Frericks10,11 Eike Steinmann10,12,13 Lei Qin14 Yunjie Lu15 Bei Jiang16 Lin Wang17
Affiliations 17 institutions
  1. Department of Microbiology and Infectious Disease Center, Beijing Key Laboratory for Research and Translation of Immunological and Molecular Diagnostic Technologies for Major Viral Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China. Electronic address: [email protected].
  2. Department of Microbiology and Infectious Disease Center, Beijing Key Laboratory for Research and Translation of Immunological and Molecular Diagnostic Technologies for Major Viral Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
  3. State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361102, China.
  4. Department of Hepatobiliary Surgery, Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
  5. The Second People's Hospital Affiliated to Tianjin Medical University, Tianjin, 300192, China.
  6. State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China.
  7. Division of Infectious Diseases, Anschutz Medical Campus, University of Colorado School of Medicine, Aurora, CO 80045, USA.
  8. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, China-Singapore Belt and Road Joint Laboratory on Infection Research and Drug Development, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine.
  9. State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, 150069, China.
  10. Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany
  11. Hepatitis E Virus Research Hub (HepE-Hub), Bochum, Germany.
  12. Hepatitis E Virus Research Hub (HepE-Hub), Bochum, Germany
  13. German Centre for Infection Research, External Partner Site, Bochum, Germany.
  14. Department of Hepatobiliary Surgery, Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: [email protected].
  15. Department of Hepatobiliary Surgery, Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: [email protected].
  16. The Second People's Hospital Affiliated to Tianjin Medical University, Tianjin, 300192, China. Electronic address: [email protected].
  17. Department of Microbiology and Infectious Disease Center, Beijing Key Laboratory for Research and Translation of Immunological and Molecular Diagnostic Technologies for Major Viral Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China. Electronic address: [email protected].
Active Last checked 2026-09-13 03:30:13 Source: NCBI PubMed

Abstract

Hepatitis E virus (HEV) causes approximately 19.47 million symptomatic cases annually and is an emerging cause of chronic hepatitis in immunocompromised individuals. No definite evidence demonstrates that laboratory mice are susceptible to all known HEV genotypes. The factors that define the host species range of HEV remain unclear. Given the numerous genetic variants and toolkits available for mice, which permit deep mechanistic studies, we aimed to develop an inbred mouse model of HEV infection. AG129 and C57BL/6J mice were infected with HEV. Key infection parameters included HEV RNA detection by RT-PCR and RNAscope, liver function tests, histopathological examination. Single-cell RNA sequencing was employed alongside transcriptomic analysis to delineate infection dynamics and investigate virus-host interactions. We show that an emerging human-pathogenic rat-derived HEV-C1 strain can breach the species barrier and robustly infect AG129 mice. Using single-cell sequencing and RNAscope, we demonstrate viral tropism for liver macrophages and hepatocytes, providing a previously unknown single-cell atlas of intrahepatic HEV-C1 infection. We subsequently adapted this HEV-C1 isolate by serial passaging in AG129 mice. After 13 passages, the resulting mouse-adapted strain acquired the ability to infect immunocompetent C57BL/6J mice. Both the immunocompromised and immunocompetent mouse models supported efficient HEV replication and enabled antiviral and vaccine testing. CD4 depletion experiments suggest that impairment of CD4+ T cell responses may contribute to the establishment of persistent infection. We developed two mouse models using AG129 and C57BL/6J mice, both of which support efficient HEV-C1 replication. This work establishes the first immunocompetent mouse model for HEV infection. These mouse models offer a robust platform for studying HEV immunopathogenesis, evaluating antivirals and vaccines, and investigating mechanisms of cross-species transmission. PX496820, PX572923 RNA-Seq data: https://ngdc.cncb.ac.cn/gsa/ IMPACT AND IMPLICATIONS: HEV research is hampered by the lack of suitable small-animal models, and our study fills this gap by establishing two mouse models, particularly the immunocompetent C57BL/6J mouse model, which should support the use of versatile genetic and immunological tools for deep mechanistic studies in the future. This study also provides a single-cell atlas of HEV infection dynamics, revealing intrahepatic viral tropism. We identified CD4+ T cell depletion as a pivotal driver of chronic infection. These mouse models offer a robust platform for studying HEV immunopathogenesis, evaluating antivirals and vaccines, and investigating mechanisms of cross-species transmission.

Supporting text Virus Host Location
Hepatitis E virus 72 Mouse model 6 Small-animal model 1

Evidence records

7 total
Zoonotic Surveillance
2 records · 2 evidence types
Evidence type
1 records
OVE12128
Key finding

HEV RNA was detected in experimentally infected AG129 and C57BL/6J mice by RT-PCR and RNAscope.

Virus
Host
Experimental system
Location
Not specified
Supporting text

AG129 and C57BL/6J mice were infected with HEV. Key infection parameters included HEV RNA detection by RT-PCR and RNAscope, liver function tests, histopathological examination.

Method
RT-PCR | RNAscope | single-cell RNA sequencing
Sample type
liver
Evidence type
1 records
OVE12131
Key finding

In AG129 mice infected with HEV-C1, viral RNA localizes to liver macrophages and hepatocytes, indicating intrahepatic cell-type tropism.

Virus
Host
Experimental system Experimental system Experimental system
Location
Not specified
Supporting text

Using single-cell sequencing and RNAscope, we demonstrate viral tropism for liver macrophages and hepatocytes, providing a previously unknown single-cell atlas of intrahepatic HEV-C1 infection.

Method
single-cell RNA sequencing | RNAscope
Sample type
liver | single-cell RNA sequencing | RNAscope
Experimental Infection
4 records · 2 evidence types
Evidence type
2 records
OVE12129
Key finding

Hepatitis E virus (HEV-C1) infection in AG129 and C57BL/6J mice was evaluated with liver function tests and histopathology to assess disease impact.

Virus
Host
Experimental system
Location
Not specified
Supporting text

AG129 and C57BL/6J mice were infected with HEV. Key infection parameters included HEV RNA detection by RT-PCR and RNAscope, liver function tests, histopathological examination.

Method
liver function tests | histopathological examination | RT-PCR | RNAscope
Experimental system
In vivo mouse infection model (AG129 and C57BL/6J mice)
OVE12130
Key finding

CD4+ T cell depletion in mice promoted establishment of persistent HEV-C1 infection, indicating immune-modulated chronicity.

Virus
Host
Experimental system
Location
Not specified
Supporting text

CD4 depletion experiments suggest that impairment of CD4+ T cell responses may contribute to the establishment of persistent infection.

Method
CD4+ T cell depletion experiments
Experimental system
In vivo mouse infection model with CD4+ T cell depletion
Evidence type
2 records
OVE12126
Key finding

A human-pathogenic rat-derived HEV-C1 strain robustly infects AG129 mice in a controlled experiment.

Virus
Host
Experimental system Context pending
Location
Not specified
Supporting text

We show that an emerging human-pathogenic rat-derived HEV-C1 strain can breach the species barrier and robustly infect AG129 mice.

Method
RT-PCR | RNAscope | liver function tests | histopathological examination | single-cell RNA sequencing
Sample type
liver | liver function tests
Experimental system
animal challenge model (AG129 mice infected with HEV-C1)
OVE12127
Key finding

After 13 serial passages in AG129 mice, a mouse-adapted HEV-C1 strain infected immunocompetent C57BL/6J mice.

Virus
Host
Experimental system
Location
Not specified
Supporting text

After 13 passages, the resulting mouse-adapted strain acquired the ability to infect immunocompetent C57BL/6J mice.

Method
serial passaging | RT-PCR | RNAscope | histopathological examination | single-cell RNA sequencing
Sample type
liver
Experimental system
animal challenge model (C57BL/6J mice infected with mouse-adapted HEV-C1 after serial passaging in AG129 mice)
Functional Mechanism
1 records · 1 evidence types
Evidence type
1 records
OVE12132
Key finding

Serial passaging of a rat-derived HEV-C1 strain in AG129 mice produced a mouse-adapted variant that expanded host range to infect immunocompetent C57BL/6J mice.

Virus
Host
Not specified
Location
Not specified
Supporting text

We subsequently adapted this HEV-C1 isolate by serial passaging in AG129 mice. After 13 passages, the resulting mouse-adapted strain acquired the ability to infect immunocompetent C57BL/6J mice.

Mechanism types
host-range expansion | transmission fitness